Timing of therapy for latent tuberculosis infection among immigrants presenting to a U.S. public health clinic: a retrospective study
2008

Timing of Therapy for Latent Tuberculosis Infection Among Immigrants

Sample size: 1465 publication Evidence: moderate

Author Information

Author(s): Page Kathleen R, Manabe Yukari C, Adelakun Akintoye, Federline Lynn, Cronin Wendy, Campbell James D, Dorman Susan E

Primary Institution: Johns Hopkins University School of Medicine

Hypothesis

How does the timing of LTBI therapy among immigrants presenting to a public health clinic relate to their time of arrival in the U.S.?

Conclusion

Foreign-born individuals who are not referred for LTBI therapy through immigration proceedings are less likely to receive LTBI therapy within 5 years of arrival to the U.S.

Supporting Evidence

  • 1882 immigrants received LTBI therapy at Prince Georges County Health Department between 1999 and 2004.
  • 16% of all immigrants initiated therapy more than 5 years after arrival to the U.S.
  • Referral for therapy by non-immigration proceedings was the strongest predictor of initiation of therapy more than 5 years after arrival.

Takeaway

This study shows that many immigrants wait too long to get treatment for a hidden TB infection, especially if they don't go through immigration services.

Methodology

Retrospective chart review of patients prescribed LTBI treatment based on medical records from Prince Georges County Health Department.

Potential Biases

Potential bias due to the assumption that most LTBI infections were acquired in the country of origin.

Limitations

The study was limited to one county TB control program in Maryland, which may affect the generalizability of the results.

Participant Demographics

The cohort was relatively young (median age 23 years) with a slight female predominance (54%). Most patients originated from Africa (57%), Latin America & the Caribbean (28%), and Asia (11%).

Statistical Information

Confidence Interval

95% CI 1.2–2.6 for female gender; 95% CI 2.5–6.6 for age ≥ 35; 95% CI 1.3–3.0 for Latin America and the Caribbean.

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2458-8-158

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication